A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT02848651 · COMPLETED
Trial details
- NCT number
- NCT02848651
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-23
- Primary completion
- 2019-05-14
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.